Using radiofrequency to improve insulin resistance in obese post-menopausal women
Effect of Radiofrequency on Insulin Resistence in Obese Post Menopansal Women
This study is testing if radiofrequency therapy can help improve insulin resistance in obese post-menopausal women when combined with standard medical care and dietary advice.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 48 Years to 60 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT05818293 on ClinicalTrials.gov |
What this trial studies
This study investigates the effect of radiofrequency technology on insulin resistance in obese post-menopausal women. Fifty-two participants will be randomly assigned to either a treatment group receiving radiofrequency therapy combined with standard medical care and dietary advice, or a control group receiving only dietary advice. The treatment involves applying radiofrequency to the abdominal area twice a week for 30 minutes. The goal is to assess whether this intervention can improve metabolic outcomes related to insulin resistance.
Who should consider this trial
Good fit: Ideal candidates are post-menopausal women aged 48-60 with a BMI over 30 kg/m2 and a waist-hip ratio of 0.89 or more.
Not a fit: Patients with uncontrolled metabolic diseases, recent surgical procedures, or certain medical implants may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive method to improve insulin sensitivity and metabolic health in obese post-menopausal women.
How similar studies have performed: While the use of radiofrequency for metabolic conditions is emerging, this specific application in post-menopausal women with insulin resistance is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • All participants post-menopausal from at least 3 years. * All participants' ages will be ranged from 48-60 years old. * All participants BMI will exceed 30 kg/m2. * All participants waist hip ratio will be equal or more than 0, 89. Exclusion Criteria: * • Surgical liposuction within the last 12 months. * Untreated hypo- or hyperthyroidism. * Uncontrolled liver, kidney or cardiovascular disease or diabetes. * Implanted pacemaker or metal implant. * History of thrombophlebitis, any hematological disease. * No past or present neurological and musculoskeletal disorders that will have affected health condition. * No smoking and drinking habits. * No psychological problems.
Where this trial is running
Cairo
- Hadiek El Maadi center — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: Shymaa M. Mohammed, MSC — Cairo University
- Study coordinator: Shymaa M Mohammed, MSc
- Email: shymaamohammed269@gmail.com
- Phone: +201096777275
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.